# Crebanine Induces Cell Death and Alters the Mitotic Process in Renal Cell Carcinoma In Vitro

## TL;DR

Crebanine, a compound from the Stephania genus, shows promise in killing kidney cancer cells and disrupting their cell cycle, suggesting it could be a useful treatment for advanced renal cell carcinoma.

## Contribution

This study is the first to investigate the antitumor effects of crebanine specifically in renal cell carcinoma.

## Key findings

- Crebanine inhibited RCC cell proliferation and caused G1-phase cell-cycle arrest.
- Crebanine induced apoptosis in RCC cells, as evidenced by chromatin condensation and activation of apoptotic markers.
- Gene and protein analyses revealed disruption of DNA replication and mitotic processes in RCC cells treated with crebanine.

## Abstract

Advanced renal cell carcinoma (RCC) has a poor prognosis; this drives the exploration of alternative systemic therapies to identify more effective treatment options. Recent research has revealed that crebanine, an alkaloid derivative of the Stephania genus, induces apoptotic effects in various cancers; however, a thorough investigation of the role of crebanine in RCC has not been conducted thus far. For this study, we evaluated tumor cell viability, clonogenicity, cell-cycle distributions, morphological changes, and cell mortality with the aim of exploring the antitumor effects of crebanine in RCC. Furthermore, we compared gene and protein expressions using RNA sequencing analysis and Western blotting. The findings indicated that crebanine significantly inhibited RCC colonies and caused G1-phase cell-cycle arrest with sub-G1-phase accumulation, thus leading to suppressed cell proliferation and cell death. In addition, Hoechst 33342 staining was used to observe apoptotic cells, which revealed chromatin condensation and a reduction in the nuclear volume associated with apoptosis. Further, gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated that differentially expressed genes are involved in the initiation of DNA replication, centrosome duplication, chromosome congression, and mitotic processes in the cell cycle along with signaling pathways, such as I-kappaB kinase/NF-kappaB signaling, Hippo signaling, and intrinsic apoptotic pathways. Consistent with GO and KEGG analyses, increased levels of cleaved caspase-3, cleaved caspase-7, and cleaved PARP, and decreased levels of cIAP1, BCL2, survivin, and claspin were observed. Finally, the expressions of G1/S phase transition cyclin D1, cyclin E/CDK2, and cyclin A2/CDK2 complexes were downregulated. Overall, these findings supported the potential of crebanine as an adjuvant therapy in RCC.